Home » Topics » Regulatory » Patents

Patents
RSS

Bayer Schering Pharma and AstraZeneca claim GR ligands as anti-inflammatory agents

July 3, 2009

Bristol-Myers Squibb describes SERT and NK1R antagonists

July 2, 2009

Kyowa Hakko Kirin presents novel glucocorticoid receptor ligands

July 2, 2009

Vertex claims inhibitors of voltage-gated sodium channels

July 2, 2009

Abbott describes novel vitamin D receptor activators for the treatment of bone disorders

July 1, 2009

Boehringer Ingelheim discloses CGRP antagonists for the treatment of migraine

July 1, 2009

GlaxoSmithKline describes hypoxia-inducible factor prolyl hydroxylase inhibitors as antianemics

June 30, 2009

Wyeth claims PI3K/mTOR inhibitors for the treatment of cancer

June 30, 2009

Neuraxon presents dual nNOS and NE reuptake inhibitors as analgesics

June 29, 2009

Orchid Chemicals & Pharmaceuticals discovers pSTAT3/IL-6 inhibitors for cancer therapy

June 29, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...